The Association Between Decreasing Labor Analgesia Epidural Infusion and Forceps Delivery
This study has been completed.
Sponsor:
Northwestern University
Information provided by:
Northwestern University
ClinicalTrials.gov Identifier:
NCT00443560
First received: March 2, 2007
Last updated: June 22, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Results First Received: May 9, 2011
| Study Type: | Observational |
|---|---|
| Study Design: | Observational Model: Case Control; Time Perspective: Retrospective |
| Conditions: |
Labor Pain Pregnancy |
| Intervention: |
Other: Case controlled analysis of epidural labor analgesia patterns |
Participant Flow
Recruitment Details
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| The Obstetric Anesthesiology Database was used to identify parturients from the Labor and Delivery Unit of Prentice Women's Hospital of Northwestern Memorial Hospital who qualified for the study between January 2004 and October 2005. |
Pre-Assignment Details
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
Reporting Groups
| Description | |
|---|---|
| Instrumental Vaginal Delivery (IVD) | Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions. |
| Spontaneous Vaginal Delivery (SVD) | The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity. |
Participant Flow: Overall Study
| Instrumental Vaginal Delivery (IVD) | Spontaneous Vaginal Delivery (SVD) | |
|---|---|---|
| STARTED | 1081 | 1081 |
| COMPLETED | 1021 | 1051 |
| NOT COMPLETED | 60 | 30 |
| No intrathecal dose | 58 | 26 |
| Multiple pregnancies or fetal demise | 2 | 4 |
Baseline Characteristics
Reporting Groups
| Description | |
|---|---|
| Instrumental Vaginal Delivery (IVD) | Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions. |
| Spontaneous Vaginal Delivery (SVD) | The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity. |
| Total | Total of all reporting groups |
Baseline Measures
| Instrumental Vaginal Delivery (IVD) | Spontaneous Vaginal Delivery (SVD) | Total | |
|---|---|---|---|
|
Number of Participants
[units: participants] |
1081 | 1081 | 2162 |
|
Age
[units: participants] |
|||
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 1081 | 1081 | 2162 |
| >=65 years | 0 | 0 | 0 |
|
Age
[units: years] Mean ± Standard Deviation |
32 ± 3 | 31 ± 3 | 31 ± 3 |
|
Gender
[units: participants] |
|||
| Female | 1081 | 1081 | 2162 |
| Male | 0 | 0 | 0 |
|
Region of Enrollment
[units: participants] |
|||
| United States | 1081 | 1081 | 2162 |
Outcome Measures
| 1. Primary: | Number of Parturients With a Decrease in the Infusion of Epidural Analgesia During Second Stage of Labor [ Time Frame: Second stage of labor up to 3 hours ] |
| 2. Secondary: | Number of Participants With Breakthrough Pain in the First Stage of Labor [ Time Frame: Supplemental analgesia in first stage of labor (<24 hours) ] |
| 3. Secondary: | Duration of Labor Analgesia [ Time Frame: Time form initiation of labor analgesia to delivery (up to 24 hours) ] |
More Information
Certain Agreements:
Limitations and Caveats
Results Point of Contact:
Publications:
| All Principal Investigators ARE employed by the organization sponsoring the study. |
Limitations and Caveats
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| The retrospective design incurs the risk of unrecorded or unobserved data. The sample selected included all patients with neuraxial analgesia who underwent IVD, but a limited sample of SVD. |
Results Point of Contact:
Name/Title: Dr. Robert J. McCarthy, PharmD
Organization: Northwestern University Feinberg School of Medicine
phone: 312-926-9015
e-mail: r-mccarthy@northwestern.edu
Organization: Northwestern University Feinberg School of Medicine
phone: 312-926-9015
e-mail: r-mccarthy@northwestern.edu
Publications:
| Responsible Party: | Cynthia A. Wong M.D., Northwestern University |
| ClinicalTrials.gov Identifier: | NCT00443560 History of Changes |
| Other Study ID Numbers: | 0524-028 |
| Study First Received: | March 2, 2007 |
| Results First Received: | May 9, 2011 |
| Last Updated: | June 22, 2011 |
| Health Authority: | United States: Institutional Review Board |